These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15964357

  • 1. Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients.
    Galarraga MC, Gomez E, de Oña M, Rodriguez A, Laures A, Boga JA, Melon S.
    Transplant Proc; 2005 Jun; 37(5):2124-6. PubMed ID: 15964357
    [Abstract] [Full Text] [Related]

  • 2. Human beta-herpesvirus interactions in solid organ transplant recipients.
    Mendez JC, Dockrell DH, Espy MJ, Smith TF, Wilson JA, Harmsen WS, Ilstrup D, Paya CV.
    J Infect Dis; 2001 Jan 15; 183(2):179-184. PubMed ID: 11120923
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir.
    Brennan DC, Storch GA, Singer GG, Lee L, Rueda J, Schnitzler MA.
    J Infect Dis; 2000 May 15; 181(5):1557-61. PubMed ID: 10823753
    [Abstract] [Full Text] [Related]

  • 4. Ganciclovir prophylaxis and beta-herpesvirus in renal transplant recipients.
    Galarraga MC, Gomez E, de Ona M, Rodriguez A, Laures A, Boga JA, Fernandez JA, Melon S.
    Transpl Int; 2005 Aug 15; 18(8):1016-7. PubMed ID: 16008754
    [No Abstract] [Full Text] [Related]

  • 5. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H, Sawada A, Kim JY, Sashihara J, Amou K, Miyagawa H, Tanaka-Taya K, Yamanishi K, Okada S.
    Bone Marrow Transplant; 2002 Apr 15; 29(7):595-8. PubMed ID: 11979309
    [Abstract] [Full Text] [Related]

  • 6. Human herpesvirus-6 and -7 after lung and heart-lung transplantation.
    Lehto JT, Halme M, Tukiainen P, Harjula A, Sipponen J, Lautenschlager I.
    J Heart Lung Transplant; 2007 Jan 15; 26(1):41-7. PubMed ID: 17234516
    [Abstract] [Full Text] [Related]

  • 7. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
    Reischig T, Opatrny K, Bouda M, Treska V, Jindra P, Svecova M.
    Transpl Int; 2002 Dec 15; 15(12):615-22. PubMed ID: 12478408
    [Abstract] [Full Text] [Related]

  • 8. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M, Loginov R, Piiparinen H, Halme L, Höckerstedt K, Lautenschlager I.
    Transplant Proc; 2005 Mar 15; 37(2):1230-2. PubMed ID: 15848678
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK, Li CK, Chik KW, Lee V, Shing MM, Ng KC, Cheung JL, Fok TF, Cheng AF.
    J Med Virol; 2004 Apr 15; 72(4):668-74. PubMed ID: 14981771
    [Abstract] [Full Text] [Related]

  • 10. Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.
    Caïola D, Karras A, Flandre P, Boutolleau D, Scieux C, Agut H, Legendre C, Gautheret-Dejean A.
    J Med Virol; 2012 Mar 15; 84(3):450-6. PubMed ID: 22246831
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T, Nampoory MR, Johny KV, Pacsa AS, Mini Abraham P, Nair MP, Abdel-Haleem M, Samhan M, Al-Mousawi M.
    Transplant Proc; 2004 Mar 15; 36(6):1847-9. PubMed ID: 15350495
    [Abstract] [Full Text] [Related]

  • 12. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, Bonvillain RW, Taylor DE, Dhillon GS.
    J Heart Lung Transplant; 2008 Aug 15; 27(8):875-81. PubMed ID: 18656801
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y, Ito Y, Kaneko K, Shibata-Watanabe Y, Tainaka T, Sumida W, Nakamura T, Kamei H, Kiuchi T, Ando H, Kimura H.
    Transplant Proc; 2008 Dec 15; 40(10):3578-82. PubMed ID: 19100443
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E, Laurés A, Baltar JM, Melón S, Díez B, de Oña M.
    Transplant Proc; 2005 Nov 15; 37(9):3760-3. PubMed ID: 16386530
    [Abstract] [Full Text] [Related]

  • 15. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V.
    Transplantation; 2009 Feb 15; 87(3):436-44. PubMed ID: 19202451
    [Abstract] [Full Text] [Related]

  • 16. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients.
    Tong CY, Bakran A, Williams H, Cheung CY, Peiris JS.
    Transplantation; 2000 Jul 15; 70(1):213-6. PubMed ID: 10919606
    [Abstract] [Full Text] [Related]

  • 17. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN.
    Clin Microbiol Infect; 2005 Sep 15; 11(9):736-43. PubMed ID: 16104989
    [Abstract] [Full Text] [Related]

  • 18. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
    Isegawa Y, Hara J, Amo K, Osugi Y, Takemoto M, Yamanishi K, Fukunaga R, Shibata M, Ohshima A, Horiguchi Y, Sugimoto N.
    J Clin Virol; 2009 Jan 15; 44(1):15-9. PubMed ID: 18952495
    [Abstract] [Full Text] [Related]

  • 19. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP, Campbell AL, Shust GF, Kahn AR, Wistinghausen B, Posada R, Kerkar N, Shneider BL, Emre S, Herold BC.
    Transplantation; 2009 May 15; 87(9):1318-24. PubMed ID: 19424031
    [Abstract] [Full Text] [Related]

  • 20. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
    Israni A, Krok K, Cohen D, Blumberg E, Bloom RD.
    Transplant Proc; 2004 Dec 15; 36(10):3019-24. PubMed ID: 15686685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.